Aker BioMarine

Report Publication Announcement • Apr 21, 2023

Aker BioMarine ASA – Invitation to presentation of the first quarter 2023 results

Aker BioMarine ASA – Invitation to presentation of the first quarter 2023 results

Aker BioMarine will release the first quarter 2023 results on Friday 28 April 2023 at 07:00 CET.

At 09:00 CET on the same day, the management will host a webcast to present the results. Following a presentation, there will be a Q&A session where written questions can be submitted to ir@akerbiomarine.com.

The webcasted presentation will be in English. To join, please use the link that will be available at www.akerbiomarine.com/investor.

A replay of the presentation and Q&A session will be made available soon after the presentation at the same web page.

For further information, please contact

Katrine Klaveness, CFO

Mobile: +47 991 58 915

Email: Katrine.Klaveness@akerbiomarine.com

About Aker BioMarine

Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.